The association of dehydroepiandrosterone sulphate levels with bone mineral density in systemic lupus erythematosus

Clinical and Experimental Rheumatology

Volumn 15, Issue 4, 1997, Pages 387-392

  Formiga, F ^a,b   Moga, I ^a   Nolla, J M ^a   Navarro, M A ^a   Bonnin, R ^a   Roig Escofet, D ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Corticosteroids; Dehydroepiandrosterone sulphate; Osteoporosis; Systemic lupus erythematosus

Indexed keywords

STERYL SULFATASE;

ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE MINERAL; CORTICOSTEROID THERAPY; DOSE RESPONSE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TESTOSTERONE BLOOD LEVEL;

ADULT; BONE DENSITY; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OSTEOPOROSIS; PARATHYROID HORMONE; PREDNISONE; PREMENOPAUSE; SALIVA; TESTOSTERONE;

EID: 0030764759     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. FELSON DT, ZHANG Y, HANNAN MT, KIEL DP, WILSON PWF, ANDERSON JJ: The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993; 329: 1141-6.
2. LUFKIN EG, WAHNER HW, O'FALLON WM: Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 1992; 117: 1-9.
3. LAHITA RG, BRADLOW HL, KUNKEL HG, FISHMAN J: Alterations in estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum 1979; 22: 1195-8.
4. JUNGERS P, NAHOUL K, PELLISIER C: Low plasma androgens in women with active or quiescent systemic lupus erythematosus. Arthritis Rheum 1982; 25: 454-7.
5. SCHAISON G, DURAND F, MOWSZOWICS I: Effect of glucocorticoids on plasma testosterone in men. Acta Endocrinol (Copenh) 1978; 89: 126-31.
6. MacADAMS MR, WHITE RH, CHIPPS BE: Reduction of serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med 1986; 104: 648-51.
7. DHILLON VB, DAVIES MC, HALL ML, ROUND JM, ELL PJ, JACOBS HS, SNAITH ML, ISENBERG DA: Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x-ray absorptiometry. Ann Rheum Dis 1990; 49: 624-6.
8. KALLA AA, FATAAR AB, JESSOP SJ, BEWERUNGE L: Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993; 36: 1726-34.
9. FORMIGA F, MOGA I, NOLLA JM, PAC M, MITJAVILA F, ROIG-ESCOFET D: Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995; 54: 274-6.
10. PONS F, PERIS P, GUAÑABENS N, et al.: The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol 1995; 34: 742-6.
11. NAVARRO MA, GÓMEZ JM, VILLABONA C, BONNIN MR: Salivary testosterone: a good measure to reflect free testosterone. Arch Intern Med 1987; 177: 1189.
12. TAN EM, COHEN AS, FRIES JF, et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
13. STEINBROCKER O, TRAEGER CH, BATTERMAN RE: Therapeutic criteria in rheumatoid arthritis. JAMA 1947; 140: 659-67.
14. ISENBERG DA, SHOENFELD Y, SCHWARTZ RS: Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus. Arthritis Rheum 1984; 27: 132-8.
15. WORLD HEALTH ORGANISATION: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series, No. 843. Geneva, World Health Organization, 1994.
16. VAN DEN BRINK HR, LEMS WF, VAN EVERDINGEN AA, BIJLSMA JWJ: Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis. Ann Rheum Dis 1993; 52: 302-5.
17. BHALLA M: Hormones and inmunoresponse. Ann Rheum Dis 1989; 48: 1-6 (Editorial).
18. ROSENFELD RS, HELLMAN L, GALLAGHER TF: Metabolism and interconversion of dehydroepiandrosterone and dehydroepiandrosterone sulphate. J Clin Endocrinol Metab 1972; 35: 187-93.
19. YAMAJI T, ISHIBASI M, TAKAU F, ITBASHI A, KATAYAMA S, ISHII J: Serum dehydroepiandrosterone sulphate concentrations in secondary adrenal insufficiency. J Clin Endocrinol Metab 1987; 65: 448-51.
20. SPECTOR TD, THOMPSON PW, PERRY LA, McGARRIGLE HH, EDWARS AC: The relationship between sex steroids and bone mineral content in women soon after menopause. Clin Endocrinol (Oxf) 1991; 34: 37-41.
21. TAELMAN P, KAUFMAN JM, JANSSENS X, VERMEULEN A: Persistence of increased bone resorption and possible role of dehydroepi-androsterone as a bone metabolism determinant in osteoporotic women in late postmenopause. Maturitas 1989; 11: 65-73.
22. SAMBROOK PN, EISMAN JA, CHAMPION ED, POCOCK NA: Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum 1988; 31: 973-8.
23. HALL GM, PERRY LA, SPECTOR TD: Depressed levels of dehydroepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density. Ann Rheum Dis 1993; 52: 211-14.
24. LAHITA RG, BRADLOW HL, GINZLER E, PANG S, NEW M: Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1987; 30: 241-8.
25. HEDMAN M, NILSSON E, DE LA TORRE B: Low sulphoconjugated steroid hormone levels in systemic lupus erythematosus (SLE). Clin Exp Rheumatol 1989; 7: 583-8.
26. NAVARRO MA, VIDALLER A, ORTOLÁ JB, BONNIN MR, PAC MV, MOGA I: Salivary testosterone levels in women with systemic lupus erythematosus. Arthritis Rheum 1992; 35: 557-9.
27. TAM CS, HEERSCHE JNM, MURRAY TM, PARSONS JA: Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology 1982; 110: 506-12.
28. FINKELSTEIN JS, KLIBANSKI A, SCHAEFER ES, HORSTEIN MD, SCHIFF I, NEER RM: Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med 1994; 331: 1618-23.
29. COSMAN F, SHEN V, XIE F, SEIBEL M, RATCLIFFE A, LINDSAY R: Estrogen protection against bone resorbing effects of parathyroid hormone infusion. Assessment by use of biochemical markers. Ann Intern Med 1993; 118: 337-43.
30. HOUSSIAU FA, LEFEBRE C, DEPRESSEUX G, LAMBERT M, DEVOGELAER JP, NAGANT DE DEUXCHAISNES C: Trabecular and cortical bone loss in systemic lupus erythematosus. Br J Rheumatol 1996; 35: 24-47.
31. LUKERT BP, RAISZ LG: Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990, 112: 352-64.
32. MANOLAGAS SC, RL JILKA: Bone marrow, cytokines, and bone remodeling. Emerging insights into pathophysiology of osteoporosis. N Engl J Med 1995; 332: 305-11.